In a new Health Affairs Forefront piece titled “As Medicaid Continuous Coverage Requirement Ends, Randomized Controlled Trials Can Minimize Churn” with co-authors Jacob Wallace and Atheendar Venkataramani, professors at the Yale School of Public Health and the Perelman School of Medicine at the University of Pennsylvania, respectively, we discuss the opportunity to use RCTs to identify strategies for communicating with Medicaid enrollees that will help minimize coverage loss.